These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 38343540)
1. EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells. Cuenca-Escalona J; Subtil B; Garcia-Perez A; Cambi A; de Vries IJM; Flórez-Grau G Front Immunol; 2024; 15():1355769. PubMed ID: 38343540 [TBL] [Abstract][Full Text] [Related]
2. Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors. Francica BJ; Holtz A; Lopez J; Freund D; Chen A; Wang D; Powell D; Kipper F; Panigrahy D; Dubois RN; Whiting CC; Prasit P; Dubensky TW Cancer Res Commun; 2023 Aug; 3(8):1486-1500. PubMed ID: 37559947 [TBL] [Abstract][Full Text] [Related]
3. PGE2-EP4 signaling steers cDC2 maturation toward the induction of suppressive T-cell responses. Cuenca-Escalona J; Flórez-Grau G; van den Dries K; Cambi A; de Vries IJM Eur J Immunol; 2024 Mar; 54(3):e2350770. PubMed ID: 38088451 [TBL] [Abstract][Full Text] [Related]
4. EP2/EP4 targeting prevents tumor-derived PGE2-mediated immunosuppression in cDC2s. Cuenca-Escalona J; Bödder J; Subtil B; Sánchez-Sánchez M; Vidal-Manrique M; Sweep MWD; Fauerbach JA; Cambi A; Flórez-Grau G; de Vries JM J Leukoc Biol; 2024 Nov; 116(6):1554-1567. PubMed ID: 39041661 [TBL] [Abstract][Full Text] [Related]
5. PGE2-EP2/EP4 signaling elicits mesoCAR T cell immunosuppression in pancreatic cancer. Akbari B; Soltantoyeh T; Shahosseini Z; Jadidi-Niaragh F; Hadjati J; Brown CE; Mirzaei HR Front Immunol; 2023; 14():1209572. PubMed ID: 37457723 [TBL] [Abstract][Full Text] [Related]
6. Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4. van Geffen C; Deißler A; Beer-Hammer S; Nürnberg B; Handgretinger R; Renz H; Hartl D; Kolahian S Front Immunol; 2021; 12():695933. PubMed ID: 34322123 [TBL] [Abstract][Full Text] [Related]
7. Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists. Bödder J; Kok LM; Fauerbach JA; Flórez-Grau G; de Vries IJM Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674907 [TBL] [Abstract][Full Text] [Related]
8. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Obermajer N; Muthuswamy R; Lesnock J; Edwards RP; Kalinski P Blood; 2011 Nov; 118(20):5498-505. PubMed ID: 21972293 [TBL] [Abstract][Full Text] [Related]
9. Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. Holt DM; Ma X; Kundu N; Collin PD; Fulton AM J Immunother; 2012; 35(2):179-88. PubMed ID: 22306906 [TBL] [Abstract][Full Text] [Related]
10. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide. Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956 [TBL] [Abstract][Full Text] [Related]
11. T cell-intrinsic prostaglandin E Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220 [TBL] [Abstract][Full Text] [Related]
12. The prostaglandin EP4 receptor is a master regulator of the expression of PGE Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598 [TBL] [Abstract][Full Text] [Related]
13. A RIPK3-PGE Yan G; Zhao H; Zhang Q; Zhou Y; Wu L; Lei J; Wang X; Zhang J; Zhang X; Zheng L; Du G; Xiao W; Tang B; Miao H; Li Y Cancer Res; 2018 Oct; 78(19):5586-5599. PubMed ID: 30012671 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules. Vleeshouwers W; van den Dries K; de Keijzer S; Joosten B; Lidke DS; Cambi A Front Immunol; 2020; 11():613286. PubMed ID: 33643295 [TBL] [Abstract][Full Text] [Related]